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Abstract  18 
Antimicrobial use in companion animals is a largely overlooked contributor to the complex 19 
problem of antimicrobial resistance. Humans and companion animals share living spaces 20 
and some classes of antimicrobials, including those categorised as Highest Priority Critically 21 
Important Antimicrobials (HPCIAs). Veterinary guidelines recommend that these agents are 22 
not used as routine first line treatment and their frequent deployment could offer a surrogate 23 
measure of ‘inappropriate’ antimicrobial use. Anthropological methods provide a 24 
complementary means to understand how medicines use makes sense ‘on-the-ground’ and 25 




This mixed-methods study sought to investigate antimicrobial use in companion animals 28 
whilst considering the organisational context in which increasing numbers of veterinarians 29 
work. Its aims were to i) to epidemiologically analyse the variation in the percentage of 30 
antimicrobial events comprising of HPCIAs in companion animal dogs attending UK clinics 31 
belonging to large veterinary groups and, ii) to analyse how the organisational structure of 32 
companion animal practice influences antimicrobial use, based on insight gained from 33 
anthropological fieldwork. 34 
 35 
A VetCompassTM dataset composed of 468,665 antimicrobial dispensing events in 240,998 36 
dogs from June 2012 to June 2014 was analysed. A hierarchical model for HPCIA usage 37 
was built using a backwards elimination approach with clinic and dog identity numbers 38 
included as random effects, whilst veterinary group, age quartile, breed and clinic region 39 
were included as fixed effects. The largest odds ratio of an antimicrobial event comprising of 40 
a HPCIA by veterinary group was 7.34 (95% confidence interval 5.14 – 10.49), compared to 41 
the lowest group (p<0.001). Intraclass correlation was more strongly clustered at dog (0.710, 42 
95% confidence interval 0.701 - 0.719) than clinic level (0.089, 95% confidence interval 43 
0.076 -0.104). This suggests that veterinarians working in the same clinic do not 44 
automatically share ways of working with antimicrobials. Fieldwork revealed how the 45 
structure of the companion animal veterinary sector was more fluid than that depicted in the 46 
statistical model, and identified opportunities and challenges regarding altering antimicrobial 47 
use. These findings were organised into the following themes: “Highest priority what?”; “He’s 48 
just not himself”; “Oh no – here comes the antibiotics police”; “We’re like ships that pass in 49 
the night”; and “There’s not enough hours in the day”. 50 
 51 
This rigorous mixed-methods study demonstrates the importance of working across 52 
disciplinary silos when tackling the complex problem of antimicrobial resistance. The findings 53 
 
3 
can help inform the design of sustainable stewardship schemes for the companion animal 54 
veterinary sector. 55 
 56 
Keywords  57 
Antibiotic, Antimicrobial consumption, Treatment incidence, Companion animal, Social 58 
sciences, Epidemiology 59 
 60 
Introduction 61 
Antimicrobial resistance is recognised as a key threat to global health and the global 62 
economy (O’Neill, 2016). However, major initiatives seeking to tackle this complex problem 63 
have largely overlooked antimicrobial use in companion animals (UK Government, 2013; 64 
O’Neill, 2016). This is despite humans and companion animals sharing classes of 65 
antimicrobials and living spaces, circumstances that could drive the development and spread 66 
of antimicrobial resistance relevant to human health (Pomba et al., 2017). Therefore, it is 67 
important to include companion animal veterinary care within antimicrobial stewardship 68 
activities. 69 
 70 
The term antimicrobial stewardship is used to describe a range of approaches and 71 
interventions seeking to ‘optimize’ antimicrobial use (Dyar et al., 2017). It originated in 72 
human healthcare but is now applied in broader One Health contexts. In companion animal 73 
veterinary medicine, it has been interpreted as schemes to encourage the responsible use of 74 
antimicrobials by decreasing prescription rates without increasing negative patient outcomes 75 
(Allerton, 2018). The World Health Organisation (WHO) focuses stewardship efforts on 76 
antimicrobials with the strongest evidence of transmission of resistant microbes or resistance 77 
genes from animal sources to humans (World Health Organisation, 2019). These medicines, 78 
designated by the WHO as Highest Priority Critically Important Antimicrobials (HPCIAs), 79 
include third and fourth generation cephalosporins, fluoroquinolones and macrolides, which 80 
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are all also available for use by companion animal veterinarians (National Office of Animal 81 
Health, 2019). 82 
 83 
Epidemiological programmes such as VetCompassTM (O'Neill, 2013) and Small Animal 84 
Veterinary Surveillance Network (SAVSNET) (Radford et al., 2010) collate anonymised 85 
electronic patient records (EPRs) from primary-care veterinary clinics and enable the 86 
quantification of antimicrobial use in the wider companion animal population (Buckland et al., 87 
2016; Singleton et al., 2017). In the United Kingdom (UK), antimicrobials are routinely 88 
prescribed for companion animals: over a two-year period, 25.2% of dogs and 20.6% of cats 89 
attending a veterinary clinic were given at least one antimicrobial treatment, with HPCIAs 90 
accounting for around five percent of antimicrobial prescribing events in dogs (Buckland et 91 
al., 2016). Unlike the livestock sector (O'Neill, 2016; Veterinary Medicines Directorate, 92 
2019), there are no published target levels for appropriate antimicrobial use in companion 93 
animals; however, professional bodies such as the British Veterinary Association (2015) and 94 
the British Small Animal Veterinary Association (2018) advise that HPCIAs should not be 95 
routinely used as first line treatment. Variation in the use of HPCIAs could act as a surrogate 96 
measure for ‘appropriate’ antimicrobial use with a low proportion of HPCIA events amongst 97 
antimicrobial events presumed to be following this advice. This could offer potential 98 
opportunities to benchmark companion animal veterinary clinics in the future. 99 
 100 
In addition to companion animal and veterinarian characteristics (Radford et al., 2011; 101 
Hughes et al., 2012), veterinary organisational structure has been associated with 102 
antimicrobial use. For example, the proportion of companion animals receiving antimicrobials 103 
varies approximately twofold between UK practices (Radford et al., 2011). Singleton and 104 
colleagues (2017) investigated longitudinal changes in HPCIA utilisation in veterinary 105 
consultations via a model that included practice (a single veterinary business) and premises 106 
(branches that form a practice) as random effects. They identified similar amount of variance 107 
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at practice (0.225) and premise level (0.175) but did not explore the impact of belonging to 108 
different large veterinary groups. Across the UK companion animal veterinary sector, there 109 
has been increasing corporatisation in recent years with approximately half of all UK 110 
practices now belonging to large groups (Wedderburn, 2017). Understanding the context in 111 
which a growing number of companion animal veterinarians work may provide insights into 112 
where best to focus effective antimicrobial stewardship interventions. For example, 113 
identifying the organisational level at which antimicrobial use is most tightly clustered could 114 
indicate the most effective leverage point at which to intervene to change prescribing habits. 115 
 116 
The social sciences are recognised to play a crucial role in understanding antimicrobial 117 
utilisation (Chandler et al., 2016). Often cast as ‘irrational’ and ‘inappropriate’, the methods 118 
and theories of anthropology offer a means by which to ask, “what makes common sense 119 
here, and why?” in order to develop situated accounts of antimicrobial use (Denyer Willis 120 
and Chandler, 2018). The cornerstone of anthropological methods is ethnography, involving 121 
participant observation to study enacted practice – both conscious and subconscious. Such 122 
an approach can provide additional insights to extend existing understandings of 123 
antimicrobial use, especially in companion animals, which has mostly relied on surveys that 124 
can only describe self-reported behaviour (Will, 2018). Ethnographic studies have been 125 
promoted in One Health for their ability to explicate the messy complexities of everyday lives 126 
whilst situating them in their broader political, economic, historical and social contexts (Wolf, 127 
2015). This is crucial for a deeper understanding of the wider influences on antimicrobial 128 
use, beyond the moment of prescribing. Furthermore, anthropological approaches can 129 
address calls for the exploration of issues of power, professional identity and reputation with 130 
respect to veterinary prescribing of antimicrobials that, to date, remain under-scrutinised 131 
(Wood, 2016). 132 
 133 
This mixed-methods study harnesses the complementary strengths of epidemiology and 134 
anthropology. This enables the painting of a more complete picture of antimicrobial use in 135 
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companion animals, one that is, “greater than the sum of the parts” (O'Cathain et al., 2010). 136 
The goal of this research is to help inform the design of antimicrobial stewardship efforts in 137 
the companion animal veterinary sector. Therefore, the aims of this study are i) to 138 
epidemiologically analyse the variation in the percentage of antimicrobial events comprising 139 
of HPCIAs in companion animal dogs attending clinics belonging to large veterinary groups 140 
and, ii) to analyse how the organisational structure of companion animal veterinary medicine 141 
influences antimicrobial use, based on insight gained from anthropological fieldwork. 142 
 143 
Materials and methods 144 
Epidemiological study 145 
Design 146 
A VetCompassTM dataset spanning June 2012 to June 2014 inclusive that had previously 147 
been used to quantify UK antimicrobial use (Buckland et al., 2016) was analysed. Due to the 148 
time constraints of this PhD project, the study population was limited to dogs, the most 149 
common UK companion animal species (O’Neill, 2013). The percentage of antimicrobial 150 
dispensing events comprising of HPCIAs was selected as the outcome measure, given the 151 
interest in these agents (Veterinary Medicines Directorate, 2019). In addition to the 152 
previously applied inclusion and exclusion criteria (Buckland et al., 2016), only data from 153 
corporate veterinary groups with over thirty clinics were retained (Fig. 1). Supplementary 154 
material 1 describes the full study inclusion and exclusion criteria. 155 
 156 
[Figure 1 - The flow of data through the VetCompassTM epidemiological study including the 157 
hierarchical models] 158 
 159 
Data cleaning and processing 160 
Buckland et al.’s (2016) definition of an antimicrobial agent and application to the dataset 161 
were re-used (Supplementary material 1). In brief, these were medicines that destroy or 162 
inhibit the growth of bacterial microorganisms and authorised for systemic use. Additional 163 
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HPCIA coding based on the WHO’s definition (2019) was added. As per Buckland et al.’s 164 
approach, an antimicrobial event was defined as an independent record (line) in the 165 
treatment data field of the EPR-derived dataset and, consequently, multiple events could 166 
arise from a single consultation or across multiple visits. 167 
 168 
The variable ‘any HPCIA’ was generated and coded as positive for all antimicrobial events 169 
linked to a unique dog identity number if one or more of these events comprised of an 170 
HPCIA. Dog age was calculated as the period between the birth date and the antimicrobial 171 
dispensing date; ages <0 or >24 years were coded as missing. Age was grouped a priori into 172 
quartiles to allow for non-linearity of effects and to facilitate interpretation. Dog sex was 173 
coded as male, female or missing. The 20 most prevalent dog breeds in the dataset were 174 
taken as categories, the remaining pure breeds were pooled together (‘other purebreds’) as 175 
were ‘cross breeds’. The clinic postcode was used to derive its region in the UK. 176 
 177 
Descriptive and univariable analyses 178 
Counts and percentages were calculated for each categorical variable (dog sex, breed, clinic 179 
region). Dog age was summarised for each quartile using median and interquartile range 180 
(IQR) after reviewing its distribution. The Pearson chi-square test and the Mann Whitney U 181 
test, as appropriate, checked for differences between the sample characteristics of each 182 
veterinary group (Kirkwood and Sterne, 2003). 183 
 184 
The total and average (mean, median) number of antimicrobial events and HPCIA events 185 
per dog were calculated. From the total number of antimicrobials events, the continuous 186 
outcome measure of the percentage of events compromising of HPCIAs was calculated at 187 
dog, clinic and veterinary group levels along with 95% confidence intervals (95% CIs). The 188 
distribution of the percentage of HPCIA events at a clinic level was plotted graphically. The 189 
composition of HPCIA events by veterinary group was investigated using percentages and 190 




Hierarchical modelling 193 
A multilevel logistic regression model was built for the binary outcome of whether an 194 
antimicrobial event comprised of a HPCIA (yes versus no) using complete cases 195 
(antimicrobial events with full data on dog identification number, dog age, dog sex, dog 196 
breed, clinic identification number, clinic region, veterinary group identification number) in the 197 
dataset. This was with the aim of investigating the clustering of HPCIA use within dogs, 198 
clinics and veterinary groups. Data at individual veterinarian level were not available. Dog 199 
identity number and clinic identity number were added as random effects whilst veterinary 200 
group was included as a fixed effect. Clinic and animal identities were included as random 201 
effects due to the large number of individual identities at both levels and where the interest 202 
was in adjusting for clustering at these levels rather evaluating individual animal or clinic 203 
differences. A screening criterion of a univariable p-value <0.25 was applied when 204 
considering the inclusion of additional fixed effects (dog age, sex, breed, clinic region) 205 
(Hosmer and Lemeshow, 2004). 206 
 207 
Model development used a manual backwards stepwise elimination approach. Models 208 
without dog identity number, clinic identity number or veterinary group were not considered 209 
as this would have prevented the investigation of HPCIA use at these levels. Likelihood ratio 210 
tests were used to compare the performance of the new, smaller model to the original. The 211 
estimated coefficients of the remaining variables were compared to those from the full model 212 
with all variables included to check there was no sizable change in their magnitude (Hosmer 213 
and Lemeshow, 2004). Pair-wise interaction effects between age quartile and percentage of 214 
HPCIA events in each veterinary group were evaluated. However limited computational 215 
power prevented the inclusion of an interaction term in the hierarchical modelling.  216 
 217 
Model performance was assessed using Receiver Operator Curve (ROC) statistics and 218 
Hosmer Lemeshow residuals (Hosmer and Lemeshow, 2004; Statalist, 2017). Odd Ratios 219 
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(ORs) and 95% CIs were calculated for each fixed effect variable. The intraclass correlation 220 
coefficients (ICCs) at a dog and clinic level were calculated to assess the clustering of 221 
HPCIA use, that is the correlation among observations within the same cluster (Dohoo et al., 222 
2003). 223 
 224 
Due to the imbalanced structure of the dataset with most dogs having a single antimicrobial 225 
event, the analyses were re-run i) in the same model using a dataset limited to dogs with 226 
multiple antimicrobial events only (model 2) and ii) a model with a binary outcome of whether 227 
a dog received any HPCIA (model 3) (Fig.1). The ICCs and performance of these models 228 
were compared to the main model (model 1) to assess the robustness of the estimates 229 
produced. 230 
 231 
Data analyses were conducted in Stata 16 (StataCorp, Texas, USA) and statistical 232 
significance was set at the 5% level. These analyses were covered by the VetCompassTM 233 
research ethics approval from the Royal Veterinary College’s Ethics and Welfare Committee 234 
(SR2018-1652). 235 
 236 
Anthropological study 237 
Data collection 238 
Fieldwork was undertaken by the lead author (AT) over nine months in 2019 at three UK 239 
companion animal clinic sites belonging to different large veterinary groups (two commercial 240 
and one charitable). The extended nature of placements enabled the researcher to become 241 
embedded in the clinic teams who became less conscious of being ‘studied’. All aspects of 242 
daily clinic life were observed including consultations, surgical procedures, administrative 243 
and reception duties. The researcher’s non-veterinary background facilitated a ‘fresh pair of 244 
eyes’ (an ‘etic’ view) on taken-for-granted situations, illuminating the unwritten rules 245 
surrounding companion animal veterinary work that become self-evident from an ‘emic’ view 246 
(Russell Bernard, 1985). Within these observation periods, informal interviews were 247 
 
10 
undertaken with veterinarians, support staff and owners to clarify arising issues. Detailed 248 
field notes describing relations, language, metaphors, and sense-making between those 249 
actors at the interface of antimicrobial use were made with attention paid to both verbal and 250 
non-verbal gestures. Additional written data sources included clinic and veterinary group 251 
policies and media articles from the mainstream and veterinary press. Semi-structured 252 
interviews were also conducted with veterinarians working at fieldwork clinics. These 253 
followed a topic guide (Supplementary material 2) but with flexibility to follow up issues 254 
raised by interviewees. The formal interviews were audio-recorded and transcribed. 255 
 256 
Data analyses 257 
The software NVivo 12 (QSR International Pty Ltd, USA) was used to organise the 258 
qualitative data and facilitate thematic coding. Initial, low level codes situated in the data – 259 
such as the activity being undertaken or topic being discussed - were developed into more 260 
abstract themes (Ziebland and McPherson, 2006). Analysis involved comparing clinics to 261 
draw out similarities and differences. Moving to a new physical space - and shifting between 262 
emic (insider) and etic (outsider) perspectives - rendered visible the enacted ‘common 263 
sense’ and supporting infrastructures (Chandler, 2019) in each location. Analyses were 264 
conducted by the first author and interim findings were discussed amongst the 265 
multidisciplinary research team. 266 
 267 
The empirical fieldwork data was considered in response to - and building on - the existing 268 
theoretical literature. Anthropologists emphasise that researchers always operate from a 269 
particular theoretical position that informs the inflection of the research: It shapes the lines of 270 
inquiry, what is tuned into in conversations, what captures the fieldworker’s gaze during 271 
observations and what is deemed noteworthy. The theoretical orientation informing this 272 
study arises from the research in anthropology and science and technology studies, 273 
influenced by the ontological turn in the social sciences, which moves from distinctions of 274 
‘nature’ and ‘culture’ to understanding ‘naturecultures’ (Haraway, 2003). Anthropologists 275 
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strive to ‘take seriously’ their interlocutors and give voice to traditionally marginalised or 276 
overlooked groups. As such, this study sought to move beyond blaming veterinarians for 277 
being irrational users of antimicrobials and beyond blaming owners for demanding 278 
antimicrobials. Instead this project wanted to understand antimicrobial prescribing as an 279 
emergent and contingent practice that is enacted under particular economic, social and 280 
material conditions (Reynolds Whyte et al., 2002). It was informed by sensory accounts of 281 
multispecies encounters (for example Kirksey and Helmreich, 2010) and material semiotic 282 
approaches that have previously been used to study care in veterinary work (Law, 2010). 283 
 284 
All study participants gave informed consent. The anthropological study was approved by 285 
the research ethics committee of London School of Hygiene and Tropical Medicine (16126). 286 
 287 
Results 288 
Epidemiological study 289 
Descriptive results 290 
The cleaned dataset contained 468,665 antimicrobial events across 240,998 dogs with 291 
294,016 (62.7%) of these events arising from veterinary group C (Table 1). Of the total 292 
antimicrobial events, 29,984 comprised of HPCIAs (6.4%, 95% CI: 6.3; 6.5%): this 293 
percentage differed between veterinary groups ranging from 4.9 % (95% CI: 4.8; 5.0) in 294 
group B to 15.6% (95% CI: 15.2%; 16.1%) in group A (p<0.001). However, the canine and 295 
clinic characteristics of antimicrobial events also varied between veterinary groups 296 
(Supplementary material 3), potentially confounding this univariable finding although this is 297 
accounted for in subsequent multivariable analyses. 298 
 299 
The types of HPCIA used varied between veterinary groups. The higher percentage of 300 
HPCIA events in group A was largely composed of fluoroquinolone use which contributed 301 
13.4% (95% CI: 12.9;13.8%) to the total antimicrobial events in this group; This compared to 302 
4.5% (95% CI: 4.4; 4.7%) in group B and 4.2% (95% CI: 4.2; 4.3%) in group C. Group B – 303 
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which had the lowest percentage of HPCIA events - had six uses of third generation 304 
cephalosporins (0.0% of antimicrobial events), suggesting they were not routinely stocked by 305 
clinics in this group. The corresponding results in groups A and C were 2.1% (95% CI: 2.0; 306 
2.3%) and 1.9% (95% CI: 1.9; 2.0%) respectively. Macrolide use was low across all groups 307 
(n = 1,137 0.2% of antimicrobial events). 308 
 309 
At a clinic level (n = 367), the median percentage of HPCIA events was 5.9 (IQR: 3.4 – 310 
10.4%) with a range of 0.0% (10 clinics) to 69.9% (1 clinic). When plotted graphically, a 311 
positively (right handed) skewed distribution with a long tail was revealed (Fig. 2). The 312 
median number of antimicrobial events per dog was 2 (IQR: 1 - 4, range: 1 - 60), whilst the 313 
median number of HPCIA events was 0 (IQR: 0 - 0, range: 0 - 60). 314 
 315 
[Figure 2 - The distribution of the percentage of antimicrobial events comprising of highest 316 
priority critically important antimicrobials by clinic (n = 367)] 317 
 318 
Hierarchical modelling results 319 
All variables met the univariable screening criterion for inclusion in the multivariable model 320 
building stage. At this point dog sex was not statistically significant and, therefore, the 321 
models comprised of clinic and dog as random effects, and corporate veterinary group, age 322 
quartile, breed and clinic region as fixed effects. 323 
 324 
Table 2 reports the main model (model 1) results: The OR of an antimicrobial event 325 
comprising of a HPCIA was statistically significantly different between veterinary groups 326 
(p<0.001) whilst and was positively associated with increasing quartiles of age. The nine 327 
breeds with the greatest OR of an HPCIA event were classified as ‘small’ (Kennel Club, no 328 
date). Compared to the South East, the OR of an event comprising of a HPCIA in Scotland 329 
was reduced (0.26, 95% CI: 0.14; 0.49) whilst the corresponding figure for an event at clinics 330 
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in the north west was 0.47 (95% CI: 0.30; 0.73). In other regions, there was no statistically 331 
significantly difference. 332 
 333 
The area under the ROC for the main model (model 1) was 0.983 (95% CI: 0.983; 0.984) 334 
and the Hosmer-Lemeshow test was non-significant (p=0.314) suggesting an acceptable 335 
model fit. When dog identity number was removed as a random effect from the main model 336 
(model 1), the area under the ROC fell to 0.712 (95% CI: 0.709; 0.715, Hosmer-Lemeshow 337 
p-value 0.231) suggesting that the information contained with dog identity number variable 338 
makes a sizeable contribution to the model’s performance. 339 
 340 
Comparison of the ICCs in the main model (model 1) suggests HPCIA use is more strongly 341 
clustered within a dog (0.710, 95% CI: 0.710; 0.719) than within a clinic (0.089, 95% CI: 342 
0.076; 0.104). These estimates were broadly similar across the models 1 to 3 343 
(Supplementary material 4). The removal of veterinary group identity number from the main 344 
model (model 1) increased the clinic level ICC only slightly to 0.118 (95% CI: 0.102; 0.136). 345 
 346 
Anthropological study 347 
The statistical model presents a representation of the companion animal veterinary work in 348 
which a dog attends a single veterinary clinic and that each clinic is a neatly bounded entity 349 
under the umbrella of a corporate veterinary group. Time in the field revealed more fluid 350 
structures which are described below. These are presented in an order to reflect the levels of 351 
the statistical model. 352 
 353 
“Highest priority what?” 354 
HPCIA – the quantitative outcome classification used in the statistical model - had little 355 
meaning ‘on the ground’. For example, antimicrobials were organised in clinic based on their 356 
formulation type (tablet, injectable) rather than other categorisations. They were referred to 357 
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by their brand names amongst staff, for instance there was awareness regarding the 358 
pressure to restrict use of Convenia (Zoetis), a third-generation cephalosporin. When 359 
outlining treatment plans to owners, it was unusual for veterinarians to present choices 360 
between different antimicrobials or describe their HPCIA status. More typically a yes/no 361 
option was proposed: ‘antibiotics’ were offered or, in some cases, suggestions were made 362 
that they should be withheld – at least initially – due to concerns about antimicrobial 363 
resistance. The reasoning behind the selection of the antimicrobial agent offered to pet 364 
owners was rarely articulated by the veterinarians.  365 
 366 
“He’s just not himself” 367 
Whether a dog received antimicrobials was shaped by a complex interplay of canine and 368 
owner characteristics. Owners determined if - and when - their dog attended the veterinary 369 
clinic and therefore could potentially access antimicrobials. Some owners presented at the 370 
first sign of trouble whilst others had to make tricky decisions about when to seek help based 371 
on limited financial and time resources. The epidemiological modelling did not investigate 372 
this entanglement of biological and social factors. 373 
 374 
Furthermore, these canine-owner knots also influenced prescribing decisions by 375 
veterinarians who assessed whether owner characteristics, such as frailty, mobility or 376 
financial hardship, may hamper antimicrobial administration or prevent return to the clinic in 377 
case of problems. Frontline veterinarians had to balance the immediate welfare needs of the 378 
animal in front of them with the less tangible risk of antimicrobial resistance. In such 379 
circumstances, the use of long-acting, injectable agents such as Convenia (Zoetis) given 380 
then and there ‘made sense’.  381 
 382 
“Oh no – here comes the antibiotics police” 383 
Due to the anonymization of information available in VetCompassTM, it was not possible to 384 
quantitatively investigate variation in HPCIA use at an individual veterinarian level. 385 
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Observations revealed that this is important with several younger veterinarians taking on the 386 
role of local antimicrobials champion. They advised and, in some cases, cajoled their co-387 
workers regarding more appropriate use. However, these champions revealed that they did 388 
not feel able to challenge all of their colleagues, in part due to their relative positions in the 389 
clinic hierarchy. 390 
 391 
“We’re like ships that pass in the night” 392 
Modern ways of working challenge the notion of the veterinary clinic as a bounded unit with 393 
a stable workforce and shared practices. Shortages of qualified staff presented ongoing 394 
challenges in the fieldwork sites with rota gaps being filled by veterinarians from other clinics 395 
or locum staff. In some cases, out-of-hours work was contracted out to separate businesses. 396 
However, the flow of staff offered opportunities to share best practice between clinics. 397 
 398 
Staffing patterns could pose issues in terms of continuity of care with pet owners no longer 399 
having a ‘usual’ veterinarian. For example, veterinarians were sometimes placed in awkward 400 
situations if pet owners had previously been seen by colleagues who had set a precedent by 401 
prescribing antimicrobials in conflict with guidelines. 402 
 403 
“There’s not enough hours in the day” 404 
Belonging to a large veterinary group presented the potential to share some of the workload 405 
associated with antimicrobial stewardship. It was difficult for frontline veterinarians to 406 
personally carve out time to undertake such activities because clinical and revenue 407 
generating activities take priority under existing business models. At one fieldwork clinic, the 408 
corporate headquarters distributed template stewardship materials for completion; however, 409 
there was limited local capacity for this work in terms of time and personnel. In another 410 
group, a single ‘top-down’, business-wide policy regarding ‘appropriate’ use was introduced 411 
but there was muted buy-in at a clinic level. The level of clinic autonomy – for example 412 
 
16 
deciding which drugs to stock – varied between veterinary groups whose organisational 413 
cultures differed. 414 
 415 
Discussion 416 
This study is the first to combine epidemiological and anthropological approaches to provide 417 
insights into antimicrobial use in the companion animal veterinary sector to help inform the 418 
design of sustainable stewardship interventions for this setting. Based on a large 419 
VetCompassTM dataset, the study quantified the variation in the percentage of antimicrobial 420 
events comprising of HPCIAs between clinics and three different veterinary groups. It also 421 
identified that relative HPCIA utilisation was more strongly clustered within dogs than within 422 
clinics. The anthropological fieldwork highlighted how the organisational structure of the 423 
companion animal veterinary sector was more fluid than that depicted in the statistical 424 
model, identifying opportunities and challenges when seeking to intervene regarding 425 
antimicrobial use. Table 3 provides a summary of the recommendations for antimicrobial 426 
stewardship schemes in companion animal veterinary practice arising from this study.  427 
 428 
The main hierarchical model suggests that the cost influences antimicrobial choice: the odds 429 
of an antimicrobial event comprising of a relatively costly HPCIA were higher in low weight 430 
breeds in which smaller – less expensive - doses are indicated. In the future, a minimum 431 
price could be applied to a HPCIA dispensing event, deterring their use in smaller dog 432 
breeds. Recognising that companion animal veterinarians make decisions based on more 433 
than clinical factors alone is important when considering how to alter antimicrobial use. 434 
Previous research has used clinical vignettes to assess ‘appropriate’ antimicrobial utilisation 435 
(Barzelai et al., 2017; Hardefeldt et al., 2017; Van Cleven et al., 2018). However, such 436 
methods overlook the day-to-day complexities faced by frontline veterinarians when making 437 
choices about antimicrobial use. The model also revealed that the odds of an antimicrobial 438 
event comprising of a HPCIA increased as dogs ages. This could be partially explained by 439 
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the contraindication for fluoroquinolones in young dogs (BSAVA, 2018) or by longitudinal 440 
changes in the common conditions treatable using antimicrobials across a dog’s life course. 441 
 442 
The quantitative study estimated that the odds of an antimicrobial event comprising a HPCIA 443 
was more tightly clustered at a dog level, perhaps reflecting their deployment in dogs with 444 
ongoing conditions. Less clustering was calculated at a clinic level suggesting that 445 
companion animal veterinarians working in the same clinic do not automatically share ways 446 
of working with antimicrobials. It was considered unlikely that within-clinic specialisation by 447 
veterinarians may have contributed to this limited within-clinic clustering, such that one 448 
clinician may be more likely to deal with dermatological conditions, for example, whilst 449 
another specialised in gastro-intestinal disorders. Within VetCompass the vast majority of 450 
work is primary care veterinary medicine with little internal referral and, as such, individual 451 
veterinarians are likely to treat the spectrum of conditions that present to a clinic. This limited 452 
clustering was echoed by the fieldwork finding that the ‘clinic’ was not found be the bounded, 453 
stable unit modelled in epidemiological studies as well as by work by Singleton et al (2017, 454 
supplementary material) where clinic premises explained little of the variance reported. 455 
 456 
A limitation of this study is that the quantitative data was from 2012 to 2014and it is unclear 457 
to what extent these patterns of antimicrobial use persist. This study period was chosen due 458 
to the presence of a pre-existing, cleaned VetCompass dataset that facilitated the 459 
undertaking of this analysis. A UK-based SAVSNET study found the percentage of HPCIA 460 
events increased slightly between 2014 and 2016 (Singleton et al., 2017). Meanwhile, in the 461 
Netherlands, a statistically significant decrease in HPCIA use was measured between 2012 462 
to 2014; however inter-clinic variation became more pronounced (Hopman et al., 2019a), 463 
perhaps suggesting differential uptake of antimicrobial stewardship messaging around 464 
HPCIA use. Subsequent to these quantitative data, the British Small Animal Veterinary 465 
Association (2018) introduced its UK stewardship campaign which included developing clinic 466 
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level antimicrobial use policies. It will be interesting to assess whether the clinic level 467 
clustering of HPCIA use has subsequently changed. 468 
 469 
From the anonymised clinical data shared with VetCompassTM, it was not possible to 470 
quantify the clustering of HPCIA use at an individual veterinarian level or include the 471 
influence of owner characteristics. Future studies could quantitatively investigate these 472 
factors. However, time spent in clinic demonstrated that the decision to use an antimicrobial 473 
arose from complex interactions including those between the consulting veterinarian and the 474 
companion animal owner, highlighting the benefits of a mixed-methods approach. A previous 475 
qualitative study reported that veterinarians feel under pressure from owners to prescribe 476 
antimicrobials; however, owners reported that it was the veterinarians themselves who 477 
encouraged their use (Smith et al., 2018). Social scientists, meanwhile, have argued that 478 
focussing on who to blame overlooks the broader structural factors supporting the continued 479 
use of antimicrobials (Chandler, 2019). Future research should further investigate the 480 
entangled roles of these actors whilst considering the context in which they operate. 481 
 482 
The percentage of antimicrobial dispensing events comprising of HPCIAs varied widely 483 
between veterinary groups largely due to variation in fluoroquinolone use. At a clinic level, a 484 
skewed distribution was observed. In the Dutch livestock sector, when defined daily 485 
antimicrobial dose per animal was plotted by farm a similarly skewed pattern was noted (Bos 486 
et al., 2015). The Netherlands Veterinary Medicines Authority used this as a basis to 487 
benchmark establishments and require that any above the 75th percentile – an arbitrary 488 
threshold – worked with their veterinarian to reduce their antimicrobial use. A similar 489 
approach could be adopted in the companion animal veterinary sector to tackle the ‘long tail’ 490 
of clinics using a higher proportion of HPCIAs. However, careful attention should be paid to 491 
the selection of any future benchmarking metric: for example, a clinic may have a high 492 
percentage of antimicrobial events comprising of HPCIAs despite a relatively small 493 
denominator (total antimicrobial events), thus masking a limited frequency of HPCIA events. 494 
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Alternatively, veterinarians might be careful users of HPCIAs but frequently prescribe other 495 
antimicrobials. Future benchmarking could account for both absolute as well as relative 496 
usage of antimicrobials overall as well as HPCIAs. 497 
 498 
On-the-ground, antimicrobial stewardship activities have to be fitted around existing, income 499 
generating workloads. Large veterinary groups may be able to shoulder some of this 500 
stewardship burden. However, the fieldwork indicates that careful reflection should be given 501 
to considering how best to ensure ‘buy-in’ by frontline veterinarians. Furthermore, the 502 
organisational culture of each veterinary group varied, suggesting an ‘off-the-shelf’ approach 503 
might have limited impact. Whilst recent graduates may be willing to act as local champions 504 
for appropriate antimicrobial use, consideration is required of how the hierarchies and 505 
gender roles at play in veterinary work (Knights and Clarke, 2019) may help or hinder these 506 
activities. 507 
 508 
To date, there has been little published research evaluating the effectiveness of 509 
interventions seeking to alter antimicrobial use in the companion animal veterinary sector 510 
although several projects are underway. Two studies (Weese, 2006; Sarrazin et al., 2017) 511 
focused on the introduction of prescribing guidelines; however, the interpretation of their 512 
findings is hampered by methodological issues such as lack of contemporaneous control 513 
groups or, in the case Sarrazin et al. (2017), the short follow-up period. Targeting the 514 
behaviour of individuals - such as prescribers - is a popular stewardship approach but also 515 
one which often has limited impact as it fails to address broader contextual issues supporting 516 
the continued use of antimicrobials (Denyer Willis and Chandler, 2019). The current study 517 
provides valuable insight into these contextual issues that, to date, have be largely 518 
overlooked when seeking to optimise antimicrobial use in the companion animals. 519 
 520 
A more recent trial (Hopman et al., 2019b) tested a multicomponent stewardship approach – 521 
which include benchmarking activities, social pledges, veterinarian education and owner 522 
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information sheets. Total antimicrobial use was reduced by 15% although there was no 523 
statistically significant reduction in HPCIA use. Clinics were reimbursed for their involvement 524 
which required considerable veterinarian participation. If Hopman et al.’s intensive approach 525 
were to be rolled out more widely, the current study suggests that financial reimbursement or 526 
provision of veterinary staff to cover clinical duties could be crucial in supporting the 527 
completion of stewardship activities. Outside of a research context, it is unclear which 528 
commercial, professional, or governmental bodies would provide these. 529 
 530 
To conclude, this rigorous mixed-methods study has provided fresh insights into 531 
antimicrobial use in the companion animal veterinary sector. In doing so, it demonstrates the 532 
strengths of working across traditional disciplinary silos to better understand and intervene in 533 
this area. By using both quantitative and qualitative approaches, it has enabled a deeper 534 
understanding of the organisational structure in which an increasing number of companion 535 
animal work and how this can influence antimicrobial use. These findings will help inform the 536 
design of sustainable stewardship interventions for this setting. 537 
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Table 1. The distribution of antimicrobial and HPCIA events by veterinary group in a 702 
VetCompassTM UK dataset from 2012 -2014. Distribution is reported in total and at a clinic 703 
level (No.: Number; HPCIA: Highest priority critical important antimicrobial; CI: confidence 704 
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Table 2. The results of the main hierarchical model (model 1) investigating HPCIA events in 709 
a VetCompassTM UK dataset of antimicrobial events from 2012 -2014 (n = 458,599) (No.: 710 
Number; HPCIA: Highest priority critical important antimicrobial; CI: confidence interval) 711 
Variable No. (%) 






B 146,802 (32.0) 1.00 
<0.0001 A 25,417 (5.5) 7.34 (5.14;10.49) 
C 286,380 (62.4) 2.04 (1.56;2.70) 
Age 
quartile 
 <1.5 years 113,060 (24.7) 1.00 
<0.0001 
1.5 to <4.3 years 116,388 (25.4) 2.12 (1.97;2.29) 
4.3 to <8.2 years 113,029 (24.6) 2.95 (2.73;3.18) 
8.2 years and over 116,122 (25.3) 5.02 (4.64;5.43) 
Breed 
Crossbreed 94,069 (20.5) 1.00 
<0.0001 
Staffordshire bull terrier 27,753 (6.1) 0.74 (0.65;0.84) 
Border collie 10,330 (2.3) 0.83 (0.68;1.01) 
Rottweiler 5,947 (1.3) 0.95 (0.74;1.23) 
Labrador retriever 35,097 (7.7) 0.96 (0.86;1.08) 
German shepherd dog 14,686 (3.2) 1.03 (0.87;1.22) 
Golden retriever 7,350 (1.6) 1.04 (0.84;1.30) 
Springer spaniel  7,708 (1.7) 1.22 (0.98;1.51) 
Jack Russell  22,303 (4.9) 1.28 (1.13;1.45) 
English springer spaniel 6,228 (1.4) 1.39 (1.11;1.74) 
Boxer 9,463 (2.1) 1.48 (1.22;1.79) 
All other pure breeds 107,008 (23.3) 1.55 (1.43;1.68) 
Border terrier 5,234 (1.1) 1.70 (1.34;2.15) 
Cavalier King Charles 
spaniel 
11,941 (2.6) 1.85 (1.57;2.18) 
Cocker spaniel 19,289 (4.2) 1.98 (1.73;2.26) 
Bichon fries 7,611 (1.7) 2.09 (1.72;2.54) 
Lhasa apso 6,490 (1.4) 2.31 (1.89;2.84) 
West highland terrier 18,115 (4.0) 2.47 (2.17;2.81) 
Shih tzu 12,618 (2.8) 2.61 (2.24;3.03) 
Yorkshire terrier 14,634 (3.2) 2.83 (2.47;3.23) 
Pug  5,849 (1.3) 3.12 (2.52;3.86) 
Chihuahua 8,836 (1.9) 3.31 (2.80;3.92) 
Clinic 
region 
South East 78,224 (17.1) 1.00 
0.0017 
Scotland 18,765 (4.1) 0.26 (0.14;0.49) 
Northern Ireland 5,567 (1.2) 0.41 (0.17;1.01) 
North West 45,192 (9.9) 0.47 (0.30;0.73) 
North East 42,324 (9.2) 0.69 (0.41;1.14) 
West Midlands 46,924 (10.2) 0.71 (0.45;1.11) 
East Midlands 54,458 (11.9) 0.71 (0.45;1.11) 
Greater London 41,402 (9.0) 0.74 (0.49;1.11) 
East of England 65,092 (14.2) 0.80 (0.55;1.16) 
South West 45,011 (9.8) 0.88 (0.59;1.40) 
Channel Islands 926 (0.2) 0.98 (0.14;6.80) 




Table 3. Recommendations for antimicrobial stewardship schemes in companion animal 713 
veterinary clinics 714 
Tailor language to reflect target audiences. 
 
Address the structural influences supporting antimicrobial use (for example their physical 
accessibility in clinic). 
 
Provide tools to support vet-owner discussions regarding antimicrobials. 
 
Make stewardship activities inclusive to all staff including those working part-time, as 
locums or hour-of-hours. 
 
Support antimicrobial champions by strengthening the evidence base regarding clinical 
outcomes when adhering to prescribing guidelines.  
 
Incorporate mandatory antimicrobial stewardship training in CPD requirements. 
 
Encourage benchmarking by the provision of accessible benchmarking tools and services 
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Figure 1 - The flow of data through the VetCompassTM epidemiological study including the 
hierarchical models 
 
Figure 2. The distribution of the percentage of antimicrobial events comprising of highest 
priority critically important antimicrobials by clinic (n = 367) 
 
 
 
